about
Unique host iron utilization mechanisms of Helicobacter pylori revealed with iron-deficient chemically defined media.Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37In vitro and in vivo complementation of the Helicobacter pylori arginase mutant using an intergenic chromosomal site.Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.Role of the HefC efflux pump in Helicobacter pylori cholesterol-dependent resistance to ceragenins and bile saltsNutritional requirements and antibiotic resistance patterns of Helicobacter species in chemically defined media.Helicobacter pylori AlpA and AlpB bind host laminin and influence gastric inflammation in gerbils.Helicobacter pylori arginase mutant colonizes arginase II knockout mice.Adherence of Helicobacter pylori to abiotic surfaces is influenced by serumA core microbiome associated with the peritoneal tumors of pseudomyxoma peritoneiPurification and characterization of Helicobacter pylori arginase, RocF: unique features among the arginase superfamily.Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects β-catenin distribution.Helicobacter pylori thioredoxin is an arginase chaperone and guardian against oxidative and nitrosative stresses.The alternative sigma factor sigmaE controls antioxidant defences required for Salmonella virulence and stationary-phase survival.Gut sterilization in experimental colitis leukocyte mediated colon injury, and effects on angiogenesis/lymphangiogenesisCellular Requirements for Cytokine Production in Response to the Immunomodulators Imiquimod and S-27609Both diet and Helicobacter pylori infection contribute to atherosclerosis in pre- and postmenopausal cynomolgus monkeys
P50
Q33826092-0E3A19B6-B5A0-4B49-9269-42C229881F9DQ34175742-9775167D-4CE1-4416-9DDA-8416B3AED190Q34237956-504353FC-1769-42EB-B514-75223995B6BBQ34255425-B8A8D6EA-55CD-444A-AE72-8400B32A343AQ34484733-B47827BE-874C-4F96-84DE-9067C96E8634Q34680804-536AF46F-1330-4907-A67C-2CC67AE2C820Q35139355-FDE56CEE-8502-4185-8908-E4CE20A309B2Q35177981-82DC1806-B0C7-4E03-B6B8-A27EA62668EFQ36482970-87D49D04-37A8-40AD-A47B-F064A5E7F124Q37059726-7DE87078-2013-4E5B-82A2-CF517CC34DF9Q44884670-D9B8E4CC-28E7-44E6-9C14-5E0EE9F23F81Q46017804-3C6CB90B-1526-423A-9638-0810BD68B59DQ46851289-53AD1BB6-A3C2-47E0-BC52-C92047540CECQ50110285-9E582FAB-EB0B-459F-A3B4-F27D596CF0F4Q58876426-F06E1618-6F86-433A-90E1-5834383B3568Q58876429-84227300-848D-4D24-9D2A-A4AFFCD573E6Q93147577-EC1EB5DF-8C5D-4587-AC17-165595A97284
P50
description
researcher, ORCID id # 0000-0002-3883-6407
@en
wetenschapper
@nl
name
Traci L Testerman
@ast
Traci L Testerman
@en
Traci L Testerman
@es
Traci L Testerman
@nl
type
label
Traci L Testerman
@ast
Traci L Testerman
@en
Traci L Testerman
@es
Traci L Testerman
@nl
prefLabel
Traci L Testerman
@ast
Traci L Testerman
@en
Traci L Testerman
@es
Traci L Testerman
@nl
P106
P1153
6602643826
P21
P31
P496
0000-0002-3883-6407